Urinary tract infections cranberry juice, underwear, and probiotics in the 21st century

Urologic Clinics of North America

Volumn 29, Issue 3, 2002, Pages 695-699

  Miller, Jane L ^a   Krieger, John N ^a,b  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; NONOXINOL 9; PROBIOTIC AGENT; SPERMICIDAL AGENT; YOGHURT;

ADULT; ALTERNATIVE MEDICINE; CLOTHING; CRANBERRY; FEMALE; FLUID INTAKE; FRUIT JUICE; HUMAN; LACTOBACILLUS FERMENTUM; LACTOBACILLUS RHAMNOSUS; MEDICAL SPECIALIST; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEXUAL INTERCOURSE; URINARY TRACT INFECTION;

CLOTHING; FEMALE; HUMANS; PHYTOTHERAPY; PLANT PREPARATIONS; PROBIOTICS; TIME FACTORS; URINARY TRACT INFECTIONS; VACCINIUM MACROCARPON;

EID: 0036704223     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(02)00057-5     Document Type: Review

References (31)

1. Glaser V. Billion dollar market blossoms as botanicals take root. Nat Biotechnol 1999;17:17-8.
2. Gupta K, Stamm W. Pathogenesis and management of recurrent urinary tract infections in women. World J Urol 1999;17:415-20.
3. Hooton T, Stamm W. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 1997;11:551-81.
4. Ronald A, Nicolle L, Stamm E, et al. Urinary tract infection in adults: Research, priorities and strategies. Int J Antimicrob Agents 2001;17:343-8.
5. Ellis A, Verma S. Quality of life in women with urinary tract infections: Is benign disease a misnomer? JABFP 2000;13:392-7.
6. Sobota A. Inhibition of bacterial adherence by cranberry juice: Potential use for the treatment of urinary tract infections. J Urol 1984;131:1013-6.
7. Zafriri D, Ofek I, Adar R, et al. Inhibitory activity of cranberry juice on adherence of type 1 and type p fimbriated Escherichia coli to eucaryotic cells. Antimicrob Agents Chemother 1989;33:92-8.
8. Avorn J, Monane M, Gurwitz H, et al. Reduction of bacteruria and pyuria after ingestion of cranberry juice. JAMA 1994;271:751-4.
9. Nicolle L. Urinary tract infection in long-term-care facility residents. Clin Infect Dis 2000;31:757-61.
10. Reid G, Bruce A, Fraser N. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol 2001;30:49-52.
11. Osset J, Bartolome R, Garcia E, et al. Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. J Infect Dis 2001;183:485-91.
12. Antonio M, Howes S, Hillier S. The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J Infect Dis 1999;180:1950-6.
13. Reid G. Probiotics in the treatment of diarrheal diseases. Curr Infect Dis Rep 2000;2:78-83.
14. Reid G, Bruce A, Taylor M. Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clin Ther 1992;14:6-11.
15. Reid G, Millsap K, Bruce A. Implantations of Lactobacillus casei var. rhamnosus into the vagina. Lancet 1994;344:1229.
16. Reid G. The scientific basis for probiotic strains of Lactobacillus. Appl Environ Microbiol 1999;65:3763-6.
17. Baerheim A, Larsen E, Digrams A. Vaginal application of lactobacilli in the Prophylaxis of recurrent lower urinary tract infection in women. Scand J Prim Health Care 1994;12:239-43.
18. Adatto K, Doebele K, Galland L, et al. Behavioral factors and urinary tract infections. JAMA 1979; 241:2525-6.
19. Ervin C, Komaroff A, Pass T. Behavioral factos and urinary tract infection [letter]. JAMA 1980;243:330-1.
20. Hooten T, Scholes D, Hughes J, et al. A prospective study of risk factors for urinary tract infection in young women. N Engl J Med 1996;335:468-74.
21. Scholes D, Hooten T, Roberts P, et al. Risk factors for recurrent urinary tract infection in young women. J Infect Dis 2000;182:1177-82.
22. Eschenbach D, Patton D, Hooton T, et al. Effects of vaginal intercourse with and without a condom on vaginal flora and vaginal epithelium. J Infect Dis 2001;183:913-8.
23. Gupta K, Hillier S, Hooton T, et al. Effects of contraceptive method on the vaginal microbial flora: A prospective evaluation. J Infect Dis 2000;181:595-601.
24. Raz R, Stamm W. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993;329:753-6.
25. Stamm W, Raz R. Factors contributing to susceptibility of postmenopausal women to recurrent urinary tract infections. Clin Infect Dis 1999; 28:723-5.
26. Raz R. Postmenopausal women with recurrent UTI. Intl J Antimicrobial Agents 2001;17:269-71.
27. Cardozo L, Lose G, McClish D, et al. A systematic review of estrogen for recurrent urinary tract infections: Third report of the hormones and urogenital therapy (HUT) committee. Int Urogynecol J Pelvic Floor Dysfunct 2001;12:15-20.
28. Uehling D, Hopkins W, Balish E, et al. Vaginal mucosal immunization for recurrent urinary tract infection: Phase II clinical trial. J Urol 1997;157:2049-52.
29. Uehling D, Hopkins W, Beierle L, et al. Vaginal mucosal immunization for recurrent urinary tract infection: Extended phase II clinical trial. J Infect Dis 2001;183(Suppl 1):S81-3.
30. Roberts J, Kaack M. FimCH vaccine against a pyelonephritis E. coli [abstract]. J Urol 2001;165:6.
31. Bichler K. Urovaxom - A metananalysis. Presented at the 7th International Symposium on Clinical Evaluation of Drug Efficacy in UTI, International Society of Chemotherapy Commission for Urinary Tract Infections, Amsterdam, 2001.